* Seagen Inc SGEN.OQ SGEN.O is expected to show a rise
in
quarterly revenue when it reports results
* The Bothell Washington-based company is expected to
report a
24.5% increase in revenue to $635.081 million from $510.3
million a year ago, according to the mean estimate from 13
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Seagen Inc is for a
loss
of 79 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 14
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Seagen Inc
is
$229, above its last closing price of $214.60.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.78 -0.81 -1.13 Missed -40.1
Mar. 31 2023 -0.82 -0.82 -0.93 Missed -13.5
Dec. 31 2022 -1.04 -1.04 -0.80 Beat 22.9
Sep. 30 2022 -0.94 -0.96 -1.03 Missed -7.7
Jun. -0.87 -0.86 -0.73 Beat 14.8
30 2022
Mar. 31 2022 -1.01 -0.99 -0.74 Beat 25.5
Dec. 31 2021 -0.83 -0.83 -0.95 Missed -14.5
Sep. 30 2021 -0.57 -0.58 -1.61 Missed -179.6
This summary was machine generated October 30 at 21:16 GMT. All
figures in US dollars unless otherwise stated